Services for usamriid generation of monoclonal antibodies (mabs)
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- W81XWH22D0013
- Awardee
-
Emory University UEI S352L5PJLMP8
- Awarding agency
-
Defense Health Agency
Department of Defense
- Task orders
- 2 $609,001 obligated
Award facts
- Opportunity
-
- W81XWH22Q0995 Solicitation number
- Combined order value
- $609,001 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 80% used
- $763,502.00
- Maximum order
- $763,502.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
Emory University was awarded a single-award indefinite delivery contract by the Defense Health Agency (DHA) to provide services for the generation of monoclonal antibodies (mAbs) for the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID). The contract has a potential value of $763,502 and runs through September 2025.
Under this IDV, Emory has received two firm fixed price delivery orders to date. The first, valued at $309,001, is for clinical trial research services associated with epitope-specific human monoclonal antibodies against Bacillus anthracis protective antigens, to be performed in Atlanta through September 2026. The second, worth $300,000, tasks Emory with providing multiplexed anthrax toxin inhibition assay services to the Department of the Army Medical Command in support of USAMRIID, to be completed by September 2023. This work is being conducted under Emory's existing $86 million indefinite delivery contract with the CDC for clinical immunization safety assessment services awarded in 2023 and running through 2028.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Clinical trial research services associated with epitrope-specific human monoclonal antibodies against bacillus… | Defense Health Agency | $309,001 | |
| Task order 1 for usamriid- multiplexed anthrax toxin inhibition assay services | Medical Command (Army) | $300,000 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract W81XWH22D0013?
W81XWH22D0013 was awarded to Emory University by Defense Health Agency (Department of Defense) on September 1, 2022.
How much is contract W81XWH22D0013 worth?
Orders under W81XWH22D0013 have obligated $609,001. W81XWH22D0013's own ceiling is $763,502. A single order can be worth up to $763,502.
How many orders have been placed under contract W81XWH22D0013?
2 orders have been placed under W81XWH22D0013, the latest on September 25, 2023.
Who can order from contract W81XWH22D0013?
W81XWH22D0013 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract W81XWH22D0013 competed?
The extent of competition for W81XWH22D0013 was not competed under sap. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV